| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2010-02-09 | 2009-12-31 | 13F-HR | Mako Surgical Corp | MAKO | US | Medical Instruments | 0 | Sold All | -147,912 | -100 % | - | - | - | 10.74 % | $-184,890 | | | | | | History of Dafna Capital Management Llc Ownership Of Mako Surgical Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cypress Bioscience Inc | CYPB | US | Therapeutics | 42,200 | Added More | 20,000 | 90.09 % | $213,532 | $209,312 | $-4,220 | -1.97 % | $-2,000 | | | | | | History of Dafna Capital Management Llc Ownership Of Cypress Bioscience Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Ziopharm Oncology Inc | ZIOP | US | Medical-Biomedical/Gene | 119,900 | Sold Some | -17,087 | -12.47 % | - | - | - | - % | | | | | | | History of Dafna Capital Management Llc Ownership Of Ziopharm Oncology Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Vital Images Inc | VTAL | US | Medical Imaging Systems | 97,109 | Sold Some | -8,679 | -8.20 % | $1,421,676 | $1,531,409 | $109,733 | 7.71 % | $-9,807 | | | | | | History of Dafna Capital Management Llc Ownership Of Vital Images Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | United Therapeutics Corp | UTHR | US | Therapeutics | 13,806 | Sold Some | -9,200 | -39.98 % | $809,446 | $786,666 | $-22,780 | -2.81 % | $15,180 | | | | | | History of Dafna Capital Management Llc Ownership Of United Therapeutics Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Trans1 Inc | TSON | US | Medical Instruments | 364,686 | Added More | 145,750 | 66.57 % | $1,145,114 | $1,367,573 | $222,458 | 19.42 % | $88,908 | | | | | | History of Dafna Capital Management Llc Ownership Of Trans1 Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Theragenics Corp | TGX | US | Therapeutics | 241,874 | Added More | 104,271 | 75.77 % | $309,599 | $360,392 | $50,794 | 16.40 % | $21,897 | | | | | | History of Dafna Capital Management Llc Ownership Of Theragenics Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Targacept Inc | TRGT | US | Medical-Drugs | 35,069 | Sold Some | -18,015 | -33.93 % | $719,265 | $669,467 | $-49,798 | -6.92 % | $25,581 | | | | | | History of Dafna Capital Management Llc Ownership Of Targacept Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Stereotaxis Inc | STXS | US | Medical Instruments | 220,000 | New Holding | 220,000 | 100 % | $935,000 | $1,152,800 | $217,800 | 23.29 % | $217,800 | | | | | | History of Dafna Capital Management Llc Ownership Of Stereotaxis Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Sonosite Inc | SONO | US | Ultra Sound Imaging Sys | 191,400 | Added More | 35,100 | 22.45 % | $5,100,810 | $6,138,198 | $1,037,388 | 20.33 % | $190,242 | | | | | | History of Dafna Capital Management Llc Ownership Of Sonosite Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Rockwell Medical Technologies Inc | RMTI | US | Medical Products | 0 | Sold All | -387,096 | -100 % | - | - | - | -18.01 % | $507,096 | | | | | | History of Dafna Capital Management Llc Ownership Of Rockwell Medical Technologies Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Rigel Pharmaceuticals Inc | RIGL | US | Medical-Drugs | 105,100 | Added More | 5,100 | 5.10 % | $955,359 | $866,024 | $-89,335 | -9.35 % | $-4,335 | | | | | | History of Dafna Capital Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Psivida Corp | PSDV | US | Medical-Biomedical/Gene | 0 | Sold All | -204,175 | -100 % | - | - | - | 15.49 % | $-108,213 | | | | | | History of Dafna Capital Management Llc Ownership Of Psivida Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Protalix Biotherapeutics Inc | PLX | US | Medical-Biomedical/Gene | 0 | Sold All | -101,402 | -100 % | - | - | - | -2.11 % | $15,210 | | | | | | History of Dafna Capital Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Pozen Inc | POZN | US | Medical-Drugs | 794,329 | Sold Some | -4 | 0.00 % | $4,559,448 | $5,536,473 | $977,025 | 21.42 % | $-5 | | | | | | History of Dafna Capital Management Llc Ownership Of Pozen Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 0 | Sold All | -67,345 | -100 % | - | - | - | 11.73 % | $-229,646 | | | | | | History of Dafna Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Nektar Therapeutics | NKTR | US | Medical-Biomedical/Gene | 174,000 | New Holding | 174,000 | 100 % | $2,037,540 | $2,674,380 | $636,840 | 31.25 % | $636,840 | | | | | | History of Dafna Capital Management Llc Ownership Of Nektar Therapeutics |
| 2010-02-09 | 2009-12-31 | 13F-HR | Natus Medical Inc | BABY | US | Medical Instruments | 0 | Sold All | -8,000 | -100 % | - | - | - | 8.91 % | $-9,360 | | | | | | History of Dafna Capital Management Llc Ownership Of Natus Medical Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Micrus Endovascular Corp | MEND | US | Medical Instruments | 77,382 | Sold Some | -8,500 | -9.89 % | $1,439,305 | $1,548,414 | $109,109 | 7.58 % | $-11,985 | | | | | | History of Dafna Capital Management Llc Ownership Of Micrus Endovascular Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Merge Healthcare Inc | MRGE | US | Medical Imaging Systems | 56,300 | New Holding | 56,300 | 100 % | $131,179 | $121,608 | $-9,571 | -7.29 % | $-9,571 | | | | | | History of Dafna Capital Management Llc Ownership Of Merge Healthcare Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Lemaitre Vascular Inc | LMAT | US | Medical Products | 0 | Sold All | -4,038 | -100 % | - | - | - | -2.47 % | $485 | | | | | | History of Dafna Capital Management Llc Ownership Of Lemaitre Vascular Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Javelin Pharmaceuticals Inc | JAV | US | Medical-Drugs | 0 | Sold All | -351,657 | -100 % | - | - | - | 17.94 % | $-73,848 | | | | | | History of Dafna Capital Management Llc Ownership Of Javelin Pharmaceuticals Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Isis Pharmaceuticals Inc | ISIS | US | Therapeutics | 754,260 | Added More | 281,300 | 59.47 % | $8,327,030 | $7,391,748 | $-935,282 | -11.23 % | $-348,812 | | | | | | History of Dafna Capital Management Llc Ownership Of Isis Pharmaceuticals Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Invacare Corp | IVC | US | Medical Products | 0 | Sold All | -24,700 | -100 % | - | - | - | 11.35 % | $-73,853 | | | | | | History of Dafna Capital Management Llc Ownership Of Invacare Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 41,100 | New Holding | 41,100 | 100 % | $641,160 | $1,550,703 | $909,543 | 141.85 % | $909,543 | | | | | | History of Dafna Capital Management Llc Ownership Of Intermune Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Insulet Corp | PODD | US | Patient Monitoring Equip | 226,881 | Sold Some | -60,100 | -20.94 % | $3,058,356 | $3,412,290 | $353,934 | 11.57 % | $-93,756 | | | | | | History of Dafna Capital Management Llc Ownership Of Insulet Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Idenix Pharmaceuticals Inc | IDIX | US | Medical-Drugs | 0 | Sold All | -167,591 | -100 % | - | - | - | -5.00 % | $25,139 | | | | | | History of Dafna Capital Management Llc Ownership Of Idenix Pharmaceuticals Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Hansen Medical Inc | HNSN | US | Diagnostic Equipment | 129,000 | New Holding | 129,000 | 100 % | $334,110 | $304,440 | $-29,670 | -8.88 % | $-29,670 | | | | | | History of Dafna Capital Management Llc Ownership Of Hansen Medical Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Halozyme Therapeutics Inc | HALO | US | Medical-Biomedical/Gene | 0 | Sold All | -23,016 | -100 % | - | - | - | 35.33 % | $-44,651 | | | | | | History of Dafna Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 106,540 | Added More | 55,800 | 109.97 % | $4,932,802 | $5,057,454 | $124,652 | 2.52 % | $65,286 | | | | | | History of Dafna Capital Management Llc Ownership Of Gilead Sciences Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 182,814 | Sold Some | -15,886 | -7.99 % | $5,382,044 | $6,669,055 | $1,287,011 | 23.91 % | $-111,837 | | | | | | History of Dafna Capital Management Llc Ownership Of Dendreon Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cytokinetics Inc | CYTK | US | Medical-Biomedical/Gene | 2,055,620 | Added More | 85,989 | 4.36 % | $6,207,972 | $6,783,546 | $575,574 | 9.27 % | $24,077 | | | | | | History of Dafna Capital Management Llc Ownership Of Cytokinetics Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cynosure Inc | CYNO | US | Medical Laser Systems | 26,900 | No Change | 0 | 0 % | $273,035 | $270,883 | $-2,152 | -0.78 % | $0 | | | | | | History of Dafna Capital Management Llc Ownership Of Cynosure Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cardionet Inc | BEAT | US | Patient Monitoring Equip | 345,300 | Added More | 169,900 | 96.86 % | $1,950,945 | $2,455,083 | $504,138 | 25.84 % | $248,054 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardionet Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cardica Inc | CRDC | US | Medical Products | 0 | Sold All | -399,202 | -100 % | - | - | - | -0.55 % | $3,992 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardica Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cardiac Science Corp | CSCX | US | Healthcare Safety Device | 868,690 | Added More | 853,460 | 5603.80 % | $2,267,281 | $1,902,431 | $-364,850 | -16.09 % | $-358,453 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardiac Science Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 55,700 | New Holding | 55,700 | 100 % | $575,938 | $505,199 | $-70,739 | -12.28 % | $-70,739 | | | | | | History of Dafna Capital Management Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Biospecifics Technologies Corp | BSTC.PK | US | Wound Burn And Skin Care | 81,482 | Added More | 21,482 | 35.80 % | - | - | - | - % | | | | | | | History of Dafna Capital Management Llc Ownership Of Biospecifics Technologies Corp |
| 2010-02-09 | 2009-12-31 | 13F-HR | Biosphere Medical Inc | BSMD | US | Medical-Biomedical/Gene | 9,461 | New Holding | 9,461 | 100 % | $25,355 | $26,491 | $1,135 | 4.47 % | $1,135 | | | | | | History of Dafna Capital Management Llc Ownership Of Biosphere Medical Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Arqule Inc | ARQL | US | Medical-Biomedical/Gene | 166,500 | New Holding | 166,500 | 100 % | $514,485 | $599,400 | $84,915 | 16.50 % | $84,915 | | | | | | History of Dafna Capital Management Llc Ownership Of Arqule Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 4,100 | No Change | 0 | 0 % | $234,561 | $235,422 | $861 | 0.36 % | $0 | | | | | | History of Dafna Capital Management Llc Ownership Of Amgen Inc |
| 2010-02-09 | 2009-12-31 | 13F-HR | Given Imaging Ltd | GIVN | IL | Medical Imaging Systems | 98,950 | Sold Some | -17,700 | -15.17 % | $1,497,114 | $1,806,827 | $309,714 | 20.68 % | $-55,401 | | | | | | History of Dafna Capital Management Llc Ownership Of Given Imaging Ltd |
| 2010-02-09 | 2009-12-31 | 13F-HR | Cardiome Pharma Corp | CRME | CA | Medical-Drugs | 1,063,374 | Sold Some | -17,500 | -1.61 % | $5,518,911 | $6,816,227 | $1,297,316 | 23.50 % | $-21,350 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardiome Pharma Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Mako Surgical Corp | MAKO | US | Medical Instruments | 147,912 | New Holding | 147,912 | 100 % | $1,371,144 | $1,905,107 | $533,962 | 38.94 % | $533,962 | | | | | | History of Dafna Capital Management Llc Ownership Of Mako Surgical Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cypress Bioscience Inc | CYPB | US | Therapeutics | 22,200 | New Holding | 22,200 | 100 % | $134,088 | $110,112 | $-23,976 | -17.88 % | $-23,976 | | | | | | History of Dafna Capital Management Llc Ownership Of Cypress Bioscience Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ziopharm Oncology Inc | ZIOP | US | Medical-Biomedical/Gene | 136,987 | New Holding | 136,987 | 100 % | - | - | - | - % | | | | | | | History of Dafna Capital Management Llc Ownership Of Ziopharm Oncology Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Vital Images Inc | VTAL | US | Medical Imaging Systems | 105,788 | Sold Some | -150,084 | -58.65 % | $1,305,424 | $1,668,277 | $362,853 | 27.79 % | $-514,788 | | | | | | History of Dafna Capital Management Llc Ownership Of Vital Images Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | United Therapeutics Corp | UTHR | US | Therapeutics | 23,006 | New Holding | 23,006 | 100 % | $1,005,132 | $1,310,882 | $305,750 | 30.41 % | $305,750 | | | | | | History of Dafna Capital Management Llc Ownership Of United Therapeutics Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Trans1 Inc | TSON | US | Medical Instruments | 218,936 | New Holding | 218,936 | 100 % | $871,365 | $821,010 | $-50,355 | -5.77 % | $-50,355 | | | | | | History of Dafna Capital Management Llc Ownership Of Trans1 Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Theragenics Corp | TGX | US | Therapeutics | 137,603 | New Holding | 137,603 | 100 % | $189,892 | $205,028 | $15,136 | 7.97 % | $15,136 | | | | | | History of Dafna Capital Management Llc Ownership Of Theragenics Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Targacept Inc | TRGT | US | Medical-Drugs | 53,084 | New Holding | 53,084 | 100 % | $1,107,863 | $1,013,374 | $-94,490 | -8.52 % | $-94,490 | | | | | | History of Dafna Capital Management Llc Ownership Of Targacept Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sonosite Inc | SONO | US | Ultra Sound Imaging Sys | 156,300 | Sold Some | -30,200 | -16.19 % | $3,915,315 | $5,012,541 | $1,097,226 | 28.02 % | $-212,004 | | | | | | History of Dafna Capital Management Llc Ownership Of Sonosite Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Savient Pharmaceuticals Inc | SVNT | US | Medical-Biomedical/Gene | 0 | Sold All | -100,000 | -100 % | - | - | - | 5.59 % | $-80,000 | | | | | | History of Dafna Capital Management Llc Ownership Of Savient Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rockwell Medical Technologies Inc | RMTI | US | Medical Products | 387,096 | New Holding | 387,096 | 100 % | $2,581,930 | $2,307,092 | $-274,838 | -10.64 % | $-274,838 | | | | | | History of Dafna Capital Management Llc Ownership Of Rockwell Medical Technologies Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rigel Pharmaceuticals Inc | RIGL | US | Medical-Drugs | 100,000 | Sold Some | -67,479 | -40.29 % | $770,000 | $824,000 | $54,000 | 7.01 % | $-36,439 | | | | | | History of Dafna Capital Management Llc Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Repros Therapeutics Inc | RPRX | US | Medical-Drugs | 0 | Sold All | -134,186 | -100 % | - | - | - | - % | | | | | | | History of Dafna Capital Management Llc Ownership Of Repros Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Psivida Corp | PSDV | US | Medical-Biomedical/Gene | 204,175 | New Holding | 204,175 | 100 % | $667,652 | $806,491 | $138,839 | 20.79 % | $138,839 | | | | | | History of Dafna Capital Management Llc Ownership Of Psivida Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Protalix Biotherapeutics Inc | PLX | US | Medical-Biomedical/Gene | 101,402 | Sold Some | -234,998 | -69.85 % | $1,118,464 | $704,744 | $-413,720 | -36.99 % | $958,792 | | | | | | History of Dafna Capital Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Pozen Inc | POZN | US | Medical-Drugs | 794,333 | Sold Some | -29,787 | -3.61 % | $5,425,294 | $5,536,501 | $111,207 | 2.04 % | $-4,170 | | | | | | History of Dafna Capital Management Llc Ownership Of Pozen Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 67,345 | Sold Some | -84,355 | -55.60 % | $1,940,209 | $2,186,019 | $245,809 | 12.66 % | $-307,896 | | | | | | History of Dafna Capital Management Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Neurocrine Biosciences Inc | NBIX | US | Therapeutics | 0 | Sold All | -253,563 | -100 % | - | - | - | 13.36 % | $-73,533 | | | | | | History of Dafna Capital Management Llc Ownership Of Neurocrine Biosciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Natus Medical Inc | BABY | US | Medical Instruments | 8,000 | New Holding | 8,000 | 100 % | $116,640 | $114,320 | $-2,320 | -1.98 % | $-2,320 | | | | | | History of Dafna Capital Management Llc Ownership Of Natus Medical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Micrus Endovascular Corp | MEND | US | Medical Instruments | 85,882 | New Holding | 85,882 | 100 % | $1,151,678 | $1,718,499 | $566,821 | 49.21 % | $566,821 | | | | | | History of Dafna Capital Management Llc Ownership Of Micrus Endovascular Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Medivation Inc | MDVN | US | Medical-Biomedical/Gene | 0 | Sold All | -66,500 | -100 % | - | - | - | -54.96 % | $1,023,435 | | | | | | History of Dafna Capital Management Llc Ownership Of Medivation Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Medarex Inc | MEDX | US | Therapeutics | 0 | Sold All | -113,200 | -100 % | - | - | - | - % | | | | | | | History of Dafna Capital Management Llc Ownership Of Medarex Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Lemaitre Vascular Inc | LMAT | US | Medical Products | 4,038 | New Holding | 4,038 | 100 % | $19,463 | $19,059 | $-404 | -2.07 % | $-404 | | | | | | History of Dafna Capital Management Llc Ownership Of Lemaitre Vascular Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Javelin Pharmaceuticals Inc | JAV | US | Medical-Drugs | 351,657 | Sold Some | -304,727 | -46.42 % | $534,519 | $485,287 | $-49,232 | -9.21 % | $42,662 | | | | | | History of Dafna Capital Management Llc Ownership Of Javelin Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Isis Pharmaceuticals Inc | ISIS | US | Therapeutics | 472,960 | Sold Some | -216,517 | -31.40 % | $6,337,664 | $4,635,008 | $-1,702,656 | -26.86 % | $779,461 | | | | | | History of Dafna Capital Management Llc Ownership Of Isis Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Intuitive Surgical Inc | ISRG | US | Medical Instruments | 0 | Sold All | -20,000 | -100 % | - | - | - | 26.93 % | $-1,508,800 | | | | | | History of Dafna Capital Management Llc Ownership Of Intuitive Surgical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Invacare Corp | IVC | US | Medical Products | 24,700 | Sold Some | -4,000 | -13.93 % | $604,656 | $724,451 | $119,795 | 19.81 % | $-19,400 | | | | | | History of Dafna Capital Management Llc Ownership Of Invacare Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Insulet Corp | PODD | US | Patient Monitoring Equip | 286,981 | Sold Some | -21,455 | -6.95 % | $3,466,730 | $4,316,194 | $849,464 | 24.50 % | $-63,507 | | | | | | History of Dafna Capital Management Llc Ownership Of Insulet Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Immunogen Inc | IMGN | US | Medical-Biomedical/Gene | 0 | Sold All | -125,000 | -100 % | - | - | - | -14.86 % | $161,250 | | | | | | History of Dafna Capital Management Llc Ownership Of Immunogen Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Idenix Pharmaceuticals Inc | IDIX | US | Medical-Drugs | 167,591 | Added More | 22,911 | 15.83 % | $331,830 | $477,634 | $145,804 | 43.93 % | $19,933 | | | | | | History of Dafna Capital Management Llc Ownership Of Idenix Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Halozyme Therapeutics Inc | HALO | US | Medical-Biomedical/Gene | 23,016 | Sold Some | -126,984 | -84.65 % | $157,429 | $171,009 | $13,579 | 8.62 % | $-74,921 | | | | | | History of Dafna Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Gilead Sciences Inc | GILD | US | Therapeutics | 50,740 | Sold Some | -5,500 | -9.77 % | $2,406,598 | $2,408,628 | $2,030 | 0.08 % | $-220 | | | | | | History of Dafna Capital Management Llc Ownership Of Gilead Sciences Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 198,700 | Sold Some | -66,100 | -24.96 % | $5,792,105 | $7,248,576 | $1,456,471 | 25.14 % | $-484,513 | | | | | | History of Dafna Capital Management Llc Ownership Of Dendreon Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cytokinetics Inc | CYTK | US | Medical-Biomedical/Gene | 1,969,631 | Sold Some | -168,000 | -7.85 % | $6,696,745 | $6,499,782 | $-196,963 | -2.94 % | $16,800 | | | | | | History of Dafna Capital Management Llc Ownership Of Cytokinetics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cynosure Inc | CYNO | US | Medical Laser Systems | 26,900 | New Holding | 26,900 | 100 % | $284,602 | $270,883 | $-13,719 | -4.82 % | $-13,719 | | | | | | History of Dafna Capital Management Llc Ownership Of Cynosure Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cardionet Inc | BEAT | US | Patient Monitoring Equip | 175,400 | Added More | 112,000 | 176.65 % | $896,294 | $1,247,094 | $350,800 | 39.13 % | $224,000 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardionet Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cardica Inc | CRDC | US | Medical Products | 399,202 | New Holding | 399,202 | 100 % | $467,066 | $714,572 | $247,505 | 52.99 % | $247,505 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardica Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cardiac Science Corp | CSCX | US | Healthcare Safety Device | 15,230 | Sold Some | -136,470 | -89.96 % | $46,452 | $33,354 | $-13,098 | -28.19 % | $117,364 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardiac Science Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Biospecifics Technologies Corp | BSTC.PK | US | Wound Burn And Skin Care | 60,000 | Added More | 57,500 | 2300.00 % | - | - | - | - % | | | | | | | History of Dafna Capital Management Llc Ownership Of Biospecifics Technologies Corp |
| 2009-11-16 | 2009-09-30 | 13F-HR | Biosphere Medical Inc | BSMD | US | Medical-Biomedical/Gene | 0 | Sold All | -10,194 | -100 % | - | - | - | -7.59 % | $2,345 | | | | | | History of Dafna Capital Management Llc Ownership Of Biosphere Medical Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 0 | Sold All | -26,900 | -100 % | - | - | - | -5.07 % | $47,344 | | | | | | History of Dafna Capital Management Llc Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aryx Therapeutics Inc | ARYX | US | Medical-Biomedical/Gene | 0 | Sold All | -388,600 | -100 % | - | - | - | -53.81 % | $520,724 | | | | | | History of Dafna Capital Management Llc Ownership Of Aryx Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Anadys Pharmaceuticals Inc | ANDS | US | Therapeutics | 0 | Sold All | -585,300 | -100 % | - | - | - | 0.00 % | $0 | | | | | | History of Dafna Capital Management Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 4,100 | No Change | 0 | 0 % | $230,174 | $235,422 | $5,248 | 2.28 % | $0 | | | | | | History of Dafna Capital Management Llc Ownership Of Amgen Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Given Imaging Ltd | GIVN | IL | Medical Imaging Systems | 116,650 | Added More | 42,500 | 57.31 % | $1,918,893 | $2,130,029 | $211,137 | 11.00 % | $76,925 | | | | | | History of Dafna Capital Management Llc Ownership Of Given Imaging Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Micromet Inc | MITI | DE | Medical-Biomedical/Gene | 0 | Sold All | -60,000 | -100 % | - | - | - | 13.79 % | $-55,200 | | | | | | History of Dafna Capital Management Llc Ownership Of Micromet Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cardiome Pharma Corp | CRME | CA | Medical-Drugs | 1,080,874 | Added More | 49,812 | 4.83 % | $4,399,157 | $6,928,402 | $2,529,245 | 57.49 % | $116,560 | | | | | | History of Dafna Capital Management Llc Ownership Of Cardiome Pharma Corp |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |